Background Cutaneous squamous cell carcinoma of the head/neck (CSCCHN) is common
due to chronic sun exposure. As CSCCHN highly expresses EGFR, we prospectively …

Objectives: The management of high-risk cutaneous squamous cell carcinoma of the head
and neck (SCCHN) is not well defined. We review outcomes in patients with locally …

Objectives The objective of this study was to investigate the safety, tolerability and
preliminary efficacy of radiotherapy plus cetuximab in high risk CSCC patients. Materials …

Results Data are available for 203 patients, 97 in arm A and 106 in arm B. Median age was
56 years (range, 21–80). Ninety-four percent of patients had pathologic Stage IV disease …

Purpose To report results of a randomized phase II trial (Radiation Therapy Oncology Group
RTOG-0234) examining concurrent chemoradiotherapy and cetuximab in the postoperative …

Locally advanced squamous cell carcinoma of the head and neck is generally managed
with a combination of surgery, RT, and/or chemotherapy or cetuximab. Appropriate …

Background Postoperative cisplatin and radiation is the standard of care for high‐risk
squamous cell carcinoma of the head and neck (SCCHN). We have used cetuximab and …

Background We conducted a multinational, randomized study to compare radiotherapy
alone with radiotherapy plus cetuximab, a monoclonal antibody against the epidermal …

Background The purpose of this study was to assess the efficacy and toxicity of docetaxel,
cisplatin/5‐fluorouracil (TPF) induction chemotherapy and concomitant …

The management of squamous cell cancer of the head and neck (SCCHN) has become
increasingly complex, because combined interdisciplinary treatment approaches including …